Aerosolized antimicrobial therapy in acutely Ill patients

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Recent data are sparking renewed interest in therapy with aerosolized antimicrobials in critically ill patients as well as other populations such as those with neutropenia, human immunodeficiency virus infection, and cystic fibrosis. Pneumonia is a common complication in these patients and is associated with substantial morbidity and increased mortality. Clinical trials evaluated aerosolized antimicrobials for the prevention and treatment of pneumonia in hospitalized patients. In addition, factors that affect the pulmonary deposition of aerosolized drugs in mechanically ventilated patients were identified.

Original languageEnglish (US)
Pages (from-to)166-181
Number of pages16
JournalPharmacotherapy
Volume20
Issue number2
DOIs
StatePublished - Jan 1 2000

Fingerprint

Pneumonia
Virus Diseases
Therapeutics
Neutropenia
Critical Illness
Cystic Fibrosis
Clinical Trials
HIV
Morbidity
Lung
Mortality
Pharmaceutical Preparations
Population

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Aerosolized antimicrobial therapy in acutely Ill patients. / Wood, G Christopher; Boucher, Bradley.

In: Pharmacotherapy, Vol. 20, No. 2, 01.01.2000, p. 166-181.

Research output: Contribution to journalReview article

@article{a1a8298d65dc4764a362ad1e7ae42f80,
title = "Aerosolized antimicrobial therapy in acutely Ill patients",
abstract = "Recent data are sparking renewed interest in therapy with aerosolized antimicrobials in critically ill patients as well as other populations such as those with neutropenia, human immunodeficiency virus infection, and cystic fibrosis. Pneumonia is a common complication in these patients and is associated with substantial morbidity and increased mortality. Clinical trials evaluated aerosolized antimicrobials for the prevention and treatment of pneumonia in hospitalized patients. In addition, factors that affect the pulmonary deposition of aerosolized drugs in mechanically ventilated patients were identified.",
author = "Wood, {G Christopher} and Bradley Boucher",
year = "2000",
month = "1",
day = "1",
doi = "10.1592/phco.20.3.166.34783",
language = "English (US)",
volume = "20",
pages = "166--181",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Aerosolized antimicrobial therapy in acutely Ill patients

AU - Wood, G Christopher

AU - Boucher, Bradley

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Recent data are sparking renewed interest in therapy with aerosolized antimicrobials in critically ill patients as well as other populations such as those with neutropenia, human immunodeficiency virus infection, and cystic fibrosis. Pneumonia is a common complication in these patients and is associated with substantial morbidity and increased mortality. Clinical trials evaluated aerosolized antimicrobials for the prevention and treatment of pneumonia in hospitalized patients. In addition, factors that affect the pulmonary deposition of aerosolized drugs in mechanically ventilated patients were identified.

AB - Recent data are sparking renewed interest in therapy with aerosolized antimicrobials in critically ill patients as well as other populations such as those with neutropenia, human immunodeficiency virus infection, and cystic fibrosis. Pneumonia is a common complication in these patients and is associated with substantial morbidity and increased mortality. Clinical trials evaluated aerosolized antimicrobials for the prevention and treatment of pneumonia in hospitalized patients. In addition, factors that affect the pulmonary deposition of aerosolized drugs in mechanically ventilated patients were identified.

UR - http://www.scopus.com/inward/record.url?scp=0033983320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033983320&partnerID=8YFLogxK

U2 - 10.1592/phco.20.3.166.34783

DO - 10.1592/phco.20.3.166.34783

M3 - Review article

C2 - 10678295

AN - SCOPUS:0033983320

VL - 20

SP - 166

EP - 181

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 2

ER -